HUMA Humacyte, Inc.

$0.57▲ +0.09% Healthcare Other
After hours $0.57▲ +0.00% Sep 11, 7:42 PM ET
Volume 2.26M Avg Volume (10D) 5.64M
Key Metrics & Fundamentals
Market Cap
$157.68M
P/E Ratio
–
Div Yield
–%
52W Range
0.53 - 2.55
% vs 50 MA
-13.93%
% vs 200 MA
-38.81%
RSI-14
40.8
MACD Histogram
+0.0000
Beta (1Y vs SPY)
3.18
Free Cash Flow
-$22.17M
Gross Rev
$406,000
Gross Profit
-$825,000
EBITDA
-$24.82M
COGS
$1.23M
Operating Exp
$26.17M
Operating Income
-$27.00M
EBIT
-$27.00M
Pretax Income
-$36.80M
Net Income
-$36.80M
EPS (Diluted)
-0.16
Price & Volume History
Loading chart…
Recent News
Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 10, 2026 12:00 PM
Humacyte Gets US FDA Clearance to Extend Symvess Shelf Life to 36 Months
MT Newswires · Sep 9, 2026 1:31 PM
Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months
GlobeNewswire · Sep 9, 2026 12:00 PM
Humacyte Plans FDA Filing for Acellular Tissue Engineered Vessel in Dialysis Access
MT Newswires · Aug 24, 2026 12:53 PM
Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions
GlobeNewswire · Aug 24, 2026 12:00 PM
Humacyte (HUMA) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 2:13 PM
Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results
GlobeNewswire · Aug 19, 2026 12:00 PM
Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”
GlobeNewswire · Aug 18, 2026 12:00 PM
Humacyte (HUMA) Faces A Fresh Test As Its $4 Fair Value Narrative Holds
Simply Wall St. · Aug 13, 2026 9:09 PM
Humacyte (HUMA) Stock Looks Stretched On Book Value Yet Reasonable After A 93% Fall
Simply Wall St. · Aug 13, 2026 12:09 PM
Financial Overview - Income Statement Quarterly

See HUMA's money flow as a full page

Social Sentiment
Avg +0.22 · 28 posts
NewsDiscussionTrade$HUMA Commercial Launch, Patent, and Upcoming Portfolio!
r/investing · Feb 27, 2025
The post highlights FDA approval, commercial launch, and patent, indicating positive developments for the company.
positive +0.70
MemeDiscussionWhat are your next big thing/under the radar picks for 2025?
r/wallstreetbets · Feb 5, 2025
The user identified HUMA as a 'stinker', indicating a negative sentiment.
negative -0.70
DiscussionTradeIs it time to panic sell????!!!!
r/wallstreetbets · Feb 3, 2025
The author expresses panic and a desire to cut losses, suggesting a negative outlook on the mentioned stocks, including HUMA.
negative +0.20
DDNewsEarningsPriceTarget$HUMA prices SYMVESS above expectations at $29,500/unit, in talks with "multiple hospitals" for commercial launch
r/wallstreetbets · Jan 13, 2025
Significant news regarding pricing and commercial launch discussions drives a positive sentiment.
positive +0.80
Rumors of HUMA's demise are greatly exaggerated
r/stocks · Jan 11, 2025
While the author defends HUMA, critiques regarding the FDA label, market size, and cost projections indicate a generally negative outlook for the stock.
negative +0.10
Page 1 of 6 (28 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙